AMGN vs RVTY
By Alex · Tickerpine
Amgen Inc. vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | RVTY |
|---|---|---|
| Price | $416.18 | $117.88 |
| Market cap | $225.15B | $13.15B |
| P/E ratio | 25.7 | 55.6 |
| ROE | 91.47% | 3.21% |
| Profit margin | 22.95% | 8.16% |
| Revenue growth | 9.50% | 1.30% |
| Dividend yield | 2.43% | 0.24% |
| Beta | 0.41 | 1.07 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs RVTY in plain English
- AMGN is the bigger company — about 17.1× the market cap of RVTY.
- AMGN is cheaper on earnings (P/E 25.7 vs 55.6).
- AMGN earns a higher return on equity (91% vs 3%).
- AMGN is growing revenue faster (10% vs 1%).
- AMGN has the higher dividend yield (2.43% vs 0.24%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.